Navigation Links
Fortune Recognizes Female Health Company as One of America's Fastest-Growing Small Companies
Date:7/7/2009

CHICAGO, July 7 /PRNewswire-FirstCall/ -- The Female Health Company (FHC) (Nasdaq-CM: FHCO) today announced that Fortune has ranked FHC eighth among the top 100 fastest-growing publicly traded small companies in America. Fortune's annual top-100 list rates companies with revenues of less than $200 million according to their annualized revenue growth and their total return to investors.

"We're thrilled that Fortune has recognized the core strengths and growth potential of Female Health Company's business model," said FHC President and CEO, O.B. Parrish. "We believe that we have built a strong private company dedicated to achieving an essential social mission - providing women with access to the female condom, the only safe and effective method of HIV prevention that women can initiate and control."

Fortune's ninth-annual review of America's top-100 small businesses placed FHC first among emerging healthcare companies, and it ranked Female Health first among small publicly traded companies based in Illinois.

The magazine also profiles FHC in a special feature article that highlights the company's recent success in developing a lower-cost, second-generation female condom (the FC2 Female Condom(R)) and winning regulatory approval for FC2 from the U.S. Food and Drug Administration (FDA) and clearance by the World Health Organization (WHO) for purchase by U.N. agencies. Reporter Elaine Appleton notes that sizable increases in U.S. funding for AIDS prevention under the President's Emergency Plan for AIDS Relief (PEPFAR), and FC2's distinction as the only woman-initiated HIV prevention method currently available, have helped to stimulate rapid growth in FC2 sales.

In 2008, FHC sold 34.7 million female condom units in 93 countries, a 34 percent increase in sales from 2007. Company revenues also rose 33 percent to $25.6 million, while net income grew 215 percent - to $4.8 million.

"FHC has made great progress over the past three years in achieving profitability and improving its margins with the development and introduction of the FC2 Female Condom," said FHC CFO Donna Felch. "FHC has succeeded in significantly reducing the female condom's cost through the introduction of a new material and a different manufacturing process. In doing so, FHC has achieved sustained growth. This is a win-win for women and the company."

FHC has also achieved success by building effective public/private partnerships with the United States Agency for International Development (USAID), the United Nations Population Fund (UNFPA) and a wide array of bilateral aid agencies, private foundations, and international NGOs committed to advancing women's access to HIV prevention. The company invests in providing technical support to public sector health programs on how to introduce the female condom and how to educate women on discussing HIV prevention with their husbands and partners.

"For more than 20 years, we have believed in the power of public/private partnership and in the principle of doing well by doing good," said FHC's Senior Strategic Advisor and former president, Dr. Mary Ann Leeper. "We are excited that years of effort in making the female condom affordable to prevention programs and accessible to women is starting to show measurable results - results that can save lives."

FHC has attracted the attention of socially responsible investment (SRI) funds such as the Appleseed Fund in recent years. Adam Strauss, a portfolio manager of the Appleseed Fund, notes that FHC meets Appleseed's two key criteria: value for investors and social sustainability. "From a value standpoint, we thought that FHC's stock price was extremely low relative to its revenue growth, its increased margins, and the company's low capital requirements," said Strauss. "From a social standpoint, FHC is in the business of saving lives, and you don't get more socially responsible than that. Their product reduces HIV transmission rates, according to studies that examine what happens when women have another HIV prevention option."

"Female Health has been a quiet grower, with few investors aware of its significant revenue and earnings growth rates until only recently, when it was added to both the NASDAQ and RUSSELL," said David Sandberg, a portfolio manager with Red Oak Partners. "We look forward to an exciting future driven off recent FDA approval for their higher margin/lower priced FC2 product, a more than doubling of FC2 production capacity in Malaysia, continued growth in FHC's partnership with a major Indian condom maker, and continued market acceptance of the FC2 product. It's a perfect storm and we remain a happy shareholder."

About The Female Health Company

The Female Health Company (FHC), headquartered in Chicago, IL, is the maker of the FC Female Condom (FC1 and FC2), a revolutionary option offering women dual protection against both sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. FHC was created as a worldwide company in February 1996 with the purchase of Chartex Resources Ltd., the holder of exclusive worldwide rights to FC1. The Company holds exclusive product and technology patents for FC1 in the United States, Australia, Brazil, Canada, France, Germany, Italy, Spain, the United Kingdom, the People's Republic of China, South Korea and Japan. FC2 patents have been granted in Australia and South Africa and are pending in various other countries. FHC is the sole manufacturer and marketer of the FC1 and FC2 female condoms in the world. The Female Health Company and its partners currently market the Female Condom under FCFemale Condom(R), FC2 Female Condom(R), Reality(R), Femidom(R), Femy(R), and Care(R).

"Safe Harbor" statement under the Private Securities Litigation Reform Action of 1995:

The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchange Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from those currently anticipated.


'/>"/>
SOURCE Female Health Company
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Allscripts Named to FORTUNE 100 Fastest-Growing Companies List
2. Laser Energetics Delivers BrightStar(TM) Alexandrite Laser to Fortune 50 Defense Company
3. Fortune 500 Executive Elected to AMA Board of Trustees
4. Fortune 100 Companies Share Customer Experience Insights in Phoenix, Ariz., Feb. 25-27
5. Medco Tops Fortunes List of Americas Most Admired Companies in its Industry
6. Fortune 500s to Convene in Florida, Sharing Insights & Best Practices for Developing Tomorrows Leaders
7. Registration Ends This Week: Fortune 500 Networking & Best Practice Sharing Conference in Florida
8. Mesa Laboratories, Inc. Named to Fortune Small Business Magazines 2008 List
9. Nuvo Research subsidiary signs collaboration agreement with Fortune Global 500 company
10. Griffin Honored with Tenth Year on FORTUNE Best Companies to Work for List
11. Novo Nordisk Makes its Debut in FORTUNEs 100 Best Companies to Work For
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER ... ensure lab personnel have a basic understanding of the techniques they use so ... understanding will help them reduce waste and rework to create a leaner overall ...
(Date:2/9/2016)... Santa Rosa, California (PRWEB) , ... February 09, 2016 , ... ... been rated one of the highest preliminary data vendors in the latest KLAS report, ... 15 years, i2i has led the developing market for population health management (PHM). ...
(Date:2/8/2016)... Bethlehem, PA (PRWEB) , ... February 08, 2016 ... ... announce expanded authorization with BASF Human Nutrition into the Food & Beverage ... BSI has been BASF’s channel partner throughout Canada and USA geographies east ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... packer for pouches, bags, and flow wrapped products at WestPack 2015, February 9-11, ... product manufacturers step up to semi-automatic or fully-automatic case packing with a small ...
(Date:2/8/2016)... Venice, FL (PRWEB) , ... February 08, 2016 ... ... their new community enrichment program serving the greater Venice, FL area, has initiated ... died tragically in a car accident just four days after Christmas. To support ...
Breaking Medicine News(10 mins):
(Date:2/9/2016)...  Misonix, Inc. (NASDAQ: MSON ), an ... markets innovative therapeutic ultrasonic products for spine surgery, ... surgery and other surgical applications, today announced financial ... half of fiscal year 2016 ended December 31, ... --> Highlights for the second quarter and ...
(Date:2/9/2016)... YORK, Pa., Feb. 9, 2016  Unilife Corporation ("Unilife" or "Company") ... of injectable drug delivery systems, today announced its financial results for ... 2015). ... Revenue for the ... million in the same period last year.  Cash receipts from customers ...
(Date:2/9/2016)... Feb. 9, 2016  Jazz Pharmaceuticals plc (Nasdaq: ... 2015 fourth quarter and full year financial results on ... financial markets.  Company management will host a live audio ... p.m. GMT to discuss fourth quarter and full year ... update and guidance for 2016 financial results. ...
Breaking Medicine Technology: